Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Update

Key Points

• Lonza Group saw a significant decrease in short interest, dropping 46.8% in September, with a total of 11,700 shares reported by September 15.
• Zacks Research downgraded Lonza Group's rating from "strong-buy" to "hold" on September 22, impacting its market perception.
• The current stock price of Lonza Group is $69.49, with a one-year range between a low of $55.57 and a high of $73.29.

Lonza Group Ag (OTCMKTS:LZAGY - Get Free Report) was the target of a large drop in short interest in the month of September. As of September 15th, there was short interest totaling 11,700 shares, a drop of 46.8% from the August 31st total of 22,000 shares. Based on an average daily volume of 70,800 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily volume of 70,800 shares, the days-to-cover ratio is currently 0.2 days.

Analysts Set New Price Targets

Separately, Zacks Research cut shares of Lonza Group from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 22nd. Two analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Lonza Group presently has an average rating of "Buy".

Lonza Group Price Performance

Lonza Group stock opened at $69.49 on Friday. The company's fifty day moving average price is $69.26 and its 200 day moving average price is $68.43. Lonza Group has a 1 year low of $55.57 and a 1 year high of $73.29.

About Lonza Group

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.